Unique T-cell Sub-Population Shifts after SBPT and Nivolumab in Platinum Refractory HNC: Biomarker Correlates from ROR1771
D.K. Ebner(Mayo Clinic in Arizona), Jaden D. Evans(Mayo Clinic), Katharine A. Price(WinnMed), H. Dong(Mayo Clinic), S.H. Patel(Mayo Clinic in Florida), M.A. Neben-Wittich(Mayo Clinic in Arizona), S.S. Park(Mayo Clinic in Arizona), L.A. McGee(Mayo Clinic Hospital), Y. Garces(Mayo Clinic), S.C. Lester(Mayo Clinic in Arizona), M.E. Gamez(Mayo Clinic in Arizona), A.V. Chintakuntlawar(Mayo Clinic in Arizona), Robert L. Foote(Mayo Clinic), JEFF EVANS(Intermountain Healthcare), Bodil Christensen(Intermountain Healthcare), J. Breinholt(Novo Nordisk (Denmark)), D.M. Routman(Mayo Clinic in Arizona)
International Journal of Radiation Oncology*Biology*Physics
September 29, 2023
Cited by 0
Related Papers
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
|Thyroid|2021|699
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2017|378
Head and Neck Cancers, Version 1.2015
|Journal of the National Comprehensive Cancer Network|2015|269